Jyothy Labs Limited is scheduled to hold a one-on-one investor meeting with ICICI Prudential on June 29, 2026. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during the interaction.

The meeting was intimated to the exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Representatives from Jyothy Labs Limited will attend the session.

The schedule of the meeting is subject to change due to exigencies on the part of the investor or the company. The latest investor presentation is available on the company's official website.

Jyothy Labs Limited has initiated arbitration at the Singapore International Arbitration Center to assert its contractual rights regarding the exit and transition mechanism for the Pril and Fa brands. This follows the company's decision to stop manufacturing, marketing, selling, and distributing these brands effective June 1, 2026, after Henkel AG & Co. KGaA communicated it would not renew the license agreements expiring on May 31, 2026. The company is pursuing legal remedies to address the end-of-term consequences, including business transfer, valuation consideration, and associated transition matters.

Agreement and Dispute Background

The License Agreements and Technology License Agreements were executed on May 31, 2011, between Erstwhile Henkel India Limited—which amalgamated with Jyothy Labs Limited—and Henkel AG & Co. KGaA. These agreements covered the manufacturing, distribution, marketing, and sale of products under the Pril and Fa brands. While commercial discussions were held for several months to explore revised terms and operational alternatives, they concluded without a mutually acceptable framework for continuation. Consequently, the company has resorted to the agreed dispute resolution process to protect its interests and those of its stakeholders.

Strategic Response and Financial Impact

Pril contributed approximately 7% to 8% of the company's total revenue, estimated broadly between ₹225 crore and ₹240 crore. Its exit will result in a near-term impact on the revenue mix and margins, with FY 2027 expected to be a transition year for the Dishwash Liquids segment. To mitigate this, Jyothy Labs is scaling up Exo Dishwash Liquid, a brand it has held since 2005-2006, which will now serve as the anchor for the company's dishwash franchise across formats. The company stated that manufacturing facilities are multiproduct and flexible, allowing for capacity redeployment without material stranded exposure. Additionally, new product developments (NPDs) across categories are planned to cover the revenue gap.

Regulatory Disclosure

The transcript of the conference call held on June 18, 2026, was submitted to BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shreyas Parag Trivedi, Head – Legal & Company Secretary, signed the disclosure on behalf of the company. Jyothy Labs confirmed that other Henkel brands, such as Henko and Mr. White, operate under perpetual license arrangements with no royalty obligations and are not affected by this development.